Pharmacists in Santa Barbara, CA Accepting Medicare
88 Pharmacists found. Showing 81 - 88
 Dr. Nishan Paul Sakadjian, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1835 Cliff Dr, Santa Barbara, CA 93109 Phone: 805-962-8709 |
 Dr. Judi Shor, PHARM.D. Pharmacist - Geriatric Medicare: Not Enrolled in Medicare Practice Location: 4630 Via Vistosa, Santa Barbara, CA 93110 Phone: 805-964-7823 Fax: 805-964-7824 |
Dr. Spencer Brown, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 35 S Milpas St, Santa Barbara, CA 93103 Phone: 805-965-0787 |
Dr. Jenny Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-569-8381 |
Rania Shenoda Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 317 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-898-3048 Fax: 805-681-1768 |
Dr. Jenna K.n. Blackman, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Ucsb Student Health Bldg 588, Santa Barbara, CA 93106 Phone: 805-893-5361 |
Jenny Huynh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1835 Cliff Dr, Santa Barbara, CA 93109 Phone: 805-962-8709 |
Fady Shenouda Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1109 State St, Santa Barbara, CA 93101 Phone: 805-564-3267 |
News Archive
Researchers highlight global burden of suboptimal fetal growth in low-and middle-income countries
In low-and middle-income countries, it is common for babies to be born of low birth weight, due to either inadequate growth in utero (fetal growth restriction) and/or preterm birth, (birth before 37 weeks gestation).
Depression both increases the risk for developing epilepsy and is also common among people with epilepsy who experience many seizures
Researchers have found provocative evidence that the brain dysfunction that underlies epilepsy may also determine whether people are at risk for suicide. The study, published online October 10, 2005 in the Annals of Neurology, also suggests that depression and suicide may have different brain mechanisms.
Trius commences oral torezolid phosphate Phase 3 clinical study for ABSSSI
Trius Therapeutics, Inc. announced that the first patient has been dosed in its Phase 3 clinical study of the oral dosage form of torezolid phosphate for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The double-blind, active control, pivotal study is designed to compare the efficacy and safety of once-daily oral administration of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment.
New chiral molecular sieves may lead to production of better drugs
An international team of researchers, led by Mark E. Davis at Caltech, has succeeded in making the first chiral molecular sieves. This discovery opens new areas of investigation in both chemistry and biology, and has broad implications for pharmaceutical companies and other specialized chemical manufacturers.
› Verified 4 days ago
Counselors
Marriage Counselors
Psychologists
Dentists
Clinical Social Workers
Pharmacists
Occupational Therapists